Emily English
Vorstandsvorsitzender bei Gemstone Biotherapeutics LLC
Vermögen: - $ am 30.04.2024
Profil
Emily P.
English is currently the Chief Executive Officer at Gemstone Biotherapeutics LLC and the SVP & Head-Manufacturing Operations at Cartesian Therapeutics, Inc. She previously worked as the Chief Executive Officer at The Johns Hopkins University.
Dr. English holds a doctorate degree from the University of Wisconsin and an undergraduate degree from the University of Maryland.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
-.--% | 18.04.2024 | 0 ( -.--% ) | - $ | 30.04.2024 |
Aktive Positionen von Emily English
| Unternehmen | Position | Beginn |
|---|---|---|
Gemstone Biotherapeutics LLC
 Gemstone Biotherapeutics LLC BiotechnologyHealth Technology Gemstone Biotherapeutics LLC develops therapeutics and devices for wound care. It develops a range of tissue engineering inventions with particular emphasis on vascularization and angiogenesis for health care research and clinical markets. The company was founded in October 2013 and is headquartered in Baltimore, MD. | Vorstandsvorsitzender | - |
Ehemalige bekannte Positionen von Emily English
| Unternehmen | Position | Ende |
|---|---|---|
| The Johns Hopkins University | Vorstandsvorsitzender | - |
Ausbildung von Emily English
| University of Maryland | Undergraduate Degree |
| University of Wisconsin | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
Gemstone Biotherapeutics LLC
Gemstone Biotherapeutics LLC BiotechnologyHealth Technology Gemstone Biotherapeutics LLC develops therapeutics and devices for wound care. It develops a range of tissue engineering inventions with particular emphasis on vascularization and angiogenesis for health care research and clinical markets. The company was founded in October 2013 and is headquartered in Baltimore, MD. | Health Technology |
